Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-20-010450

Chairman & CEO sold 251,572 shares at an average $21.02 ($5,288,013)

  • Chairman & CEO acquired 151,572 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Patel Sanj K · Chairman & CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2020-10-09 Exercise or conversion : show line 1 in the form +872 $1.59 $1,386 872 D
2020-10-09 Sale : show line 2 in the form −872 $21.00 $18,312 0 D
2020-10-09 Sale : show line 3 in the form −670 $21.00 $14,070 211,900 I
2020-10-12 Exercise or conversion : show line 4 in the form +150,700 $1.59 $239,613 150,700 D
2020-10-12 Sale : show line 5 in the form −150,700 $21.02 $3,167,714 0 D
2020-10-12 Sale : show line 6 in the form −99,330 $21.02 $2,087,917 112,570 I
Open-market sales · 251,572 sh · avg $21.02 · $5,288,013

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-10-09 Exercise or conversion : show line 7 in the form Share Option −872 502,896 D
2020-10-12 Exercise or conversion : show line 8 in the form Share Option −150,700 352,196 D
Loading xslF345X03/edgar.xml…